TransMedics Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
TransMedics Group (TMDX) Tops Q2 EPS by 13c, Revenues Beat
November 4, 2020 5:10 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q2 EPS of ($0.19), $0.13 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $5.55 million.
Recent Highlights
Net revenue of $7.1 million in the third quarter of 2020, representing a 2% decrease... More